Sharonai Holdings Inc. (SHAZ)
AI stock analysis · as of Jun 13, 2026
Loading microstructure…
SharonAI Holdings (SHAZ) is a newly-public micro-cap AI infrastructure / GPU-as-a-Service company that pivoted from Filecoin mining, IPO'd on Nasdaq in February 2026 raising ~$119.5M net, and has secured headline-grabbing contracts including a $1.26B ESDS services deal and a reported $4.88B NVIDIA/40,000-GPU collaboration in Australia. The core investment question is whether SHAZ can actually finance and execute on ~$800M+ of capital commitments against a tiny $1.6M revenue base and $164M cash pile without catastrophic dilution, or whether it is a speculative momentum vehicle priced at 685x sales that will collapse under capex needs and convertible-note conversions.
valuationExpensive on any fundamental basis — 685x P/S, 11x P/B, negative gross/operating margins, -99% ROE, and 230x debt/equity; the only support is forward optionality on $5B+ of contracted backlog, which is itself unfunded.
This analysis is from Jun 13, 2026. Want the latest on SHAZ, plus the ability to generate fresh research on demand?
Every call we make is tracked publicly against what the stock actually did. See the track record →
One free AI report every day. No card required.
Bull case
- · Massive contracted backlog signals genuine demand: $1.26B ESDS services contract, $92M WWT hardware commitment, 70 MW of contracted data center capacity, and a reported $4.88B NVIDIA/40k-GPU Australia collaboration provide visibility well beyond the current $1.6M revenue run-rate.
- · Revenue grew 257% YoY in FY2025 (from $438K to $1.57M) off the GPU pivot, and Q1 2026 cash surged to $164.3M with stockholders' equity flipping from -$10.1M to +$88.6M post-IPO — the balance sheet is materially stronger than pre-IPO.
- · Credibility build-out: Andrew Penn appointed chair, disclosed position from Leopold Aschenbrenner, and a hyperscaler-grade NVIDIA partnership lend legitimacy unusual for a 25-employee micro-cap.
- · Sell-side, though only 3 analysts, targets $78 mean ($69–$90) vs. $62 spot, implying ~25% upside, and the 52-week range ($16.55–$86.94) shows the market has been willing to re-rate violently on positive news.
- · Short interest is low (5.17% of float, 1.02 days to cover), so the stock is not structurally fighting a bear raid — positive contract news flow can drive momentum without short-squeeze distortion.
Bear case
- · Valuation is extreme on every grounded metric: 685x price/sales, 11.3x price/book, -95x EV/EBITDA, -9.3% gross margin, -959% operating margin, and -99% ROE; the forward P/E of ~19x relies entirely on speculative forward estimates that have no operating track record.
- · Capital shortfall is enormous: ~$720M of capex required for ESDS plus $92M WWT against $164M cash and -$13.6M FCF — execution requires hundreds of millions in additional equity or debt, virtually guaranteeing further dilution.
- · Convertible note overhang is severe: $199.4M fair-value convertibles (Level 3, maturing within 24 months of Dec-2025), $50M+ additional 6% senior notes raised April 2026, plus ~$97.5M already converted into 7.6M shares and $350M of new notes + 11.29M shares registered for resale.
- · Q1 2026 revenue was only $294K with a gross LOSS of -$232K and a $70.2M non-cash convertible fair-value charge — the P&L is dominated by Level 3 mark-to-model volatility rather than operating progress.
- · Dual-class structure (Class B = 160 votes/share) concentrates control with insiders Manning and Hughes-Jones (insiders hold 23.3%), limiting minority shareholder influence over dilutive financings.
- · Debt/equity of 230x and revenue growth turning negative (-9.6% on the latest TTM metric) alongside a $13.5M cash tax liability from the TCDC sale despite a net loss highlight near-term liquidity strain.
Catalysts
- · Next earnings on 2026-08-13: investors will look for ramp evidence on ESDS deployment, NVIDIA/Australia milestones, and updated capex funding plan.
- · Commencement of the 15 MW GreenSquareDC Australia capacity (targeted September 2026 start) — first material revenue inflection point.
- · Any follow-on equity raise or strategic financing to plug the ~$700M+ capex gap (could be bullish if priced well, bearish if heavily dilutive).
- · Conversion or refinancing events on the $199.4M convertibles within the 24-month window — automatic conversion at corporate events creates ~8.25M potential dilution shares.
- · Additional hyperscaler/AI-lab customer announcements or expansion of the NVIDIA collaboration scope.
- · Resale registration of 11.29M shares + notes hitting the tape could create a near-term supply shock.
Key risks
- · Going-concern style liquidity risk: negative gross margin, -$7.5M Q1 operating cash burn, and unfunded commitments dwarfing cash on hand.
- · Dilution risk from convertible conversions, the $350M shelf, and probable equity raises to fund ESDS capex.
- · Execution risk: 25 employees attempting to build out 70+ MW of data center capacity and deploy 40,000 GPUs on aggressive timelines.
- · Customer concentration: ESDS and the NVIDIA/Australia program likely dominate the pipeline; any slippage materially impairs the story.
- · Valuation reset risk if AI-infrastructure sentiment cools — at 685x sales the stock has no margin of safety on multiple compression.
- · Mark-to-model P&L volatility from Level 3 convertible note revaluations could swing reported results by tens of millions per quarter.
What to watch
- · Q2 2026 earnings on 2026-08-13 — revenue ramp, cash burn, and updated capex funding plan.
- · Any 8-K announcing follow-on equity or convertible financing; size and pricing will set the dilution tone.
- · GreenSquareDC Australia capacity start (targeted September 2026) — first real operational milestone.
- · Convertible note conversion activity and the 11.29M-share resale registration becoming effective.
- · Technical levels: 52-week low $16.55 as downside reference; $86.94 high as upside breakout level.
- · Newsflow from NVIDIA partnership scope expansion or ESDS deployment progress.
Key metrics
Price target rationale
Base case ($60) assumes the stock holds near current levels as contract progress is offset by dilution from the $350M shelf and convertible conversions, valuing the equity around current ~$1B market cap pending execution proof. Bull case ($110) assumes successful Sept-2026 Australia start, a well-received follow-on raise, and a re-rating toward analyst high ($90) plus momentum overshoot. Bear case ($18, near the 52-week low) reflects a scenario where forced dilution, convertible conversion, or contract slippage compresses the speculative premium back to tangible book.
On Wall Street's view (mixed): The $78 consensus mean is plausible if even partial execution on the ESDS and NVIDIA contracts materializes, but with only 3 analysts covering a pre-revenue micro-cap and massive dilution pending, the target carries low conviction and likely under-weights financing risk.
Latest filing (10-Q)
SharonAI is a near-zero-revenue GPU infrastructure startup that just IPO'd on Nasdaq, holds $164M cash, but faces a $199M convertible note liability, a $1.26B customer contract requiring $720M in capex it cannot yet fund, and a $70M non-cash accounting loss that masks the real story: it is a high-stakes bet on AI infrastructure demand with almost no operating track record.
SharonAI Holdings Inc. (Nasdaq: SHAZ) is a digital infrastructure company focused on providing High Performance Compute (HPC) and GPU-as-a-Service (GPUaaS) to AI, research, and data-intensive workloads. The company generates revenue primarily from GPU infrastructure services and previously from digital asset mining and Filecoin cloud storage, both of which have been wound down. It completed a SPAC business combination with Roth CH Acquisition Co. in December 2025 and listed on Nasdaq in February 2026.
What the news says · neutral
SharonAI (SHAZ) has secured a headline-grabbing $4.88B NVIDIA compute collaboration involving 40,000 GPUs in Australia, which initially sent shares surging ~25%. However, the bullish catalyst is being meaningfully offset by significant dilution concerns: the company converted ~$97.5M in notes into 7.6M shares and registered $350M in new notes alongside 11.29M shares for resale, creating substantial overhang. The stock's reported 4,000%+ YTD gain and tiny market cap suggest extreme speculative positioning, making it highly vulnerable to sentiment shifts. Positive signals like Leopold Aschenbrenner's disclosed position and Andrew Penn's appointment as chair add credibility, but the dilution risk and micro-cap volatility warrant caution.
This analysis is from Jun 13, 2026. Markets move. Get the current read on SHAZ and generate fresh AI research on any ticker.
Every call we make is tracked publicly against what the stock actually did. See the track record →
One free AI report every day. No card required.